Epstein File EFTA00292514: Holder and Memorandum (DS9)

Epstein Index›Documents›EFTA00292514

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA00292514: Holder and Memorandum (DS9)

Financial RecordDate unavailableEFTA002925141 keyword hits

0

views

0

shares

0

reactions

1

persons

1

keywords

5

excerpts

This document is a memorandum of terms for private placement of Series A-1 Preferred Stock of Angiocrine Bioscience, Inc., dated April 27, 2017. The memorandum summarizes principal financing terms, completion conditions including financial and legal due diligence, and defines significant holders as investors purchasing at least 500,000 shares, with provisions for rights of first offer and co-sale rights until the company's initial public offering or deemed liquidation event.

👤 Named in This Document

Eric Holder

🔑 Evidence Keywords

memorandum

📋 Key Excerpts5

PersonKeyword

Excerpt 1

**MEMORANDUM** OF TERMS FOR PRIVATE PLACEMENT OF SERIES A-1 PREFERRED STOCK OF ANGIOCRINE BIOSCIENCE, INC.

Excerpt 2

April 27, 2017 This **memorandum** summarizes the principal terms of the Series A-1 Preferred Stock financing of Angiocrine Bioscience, Inc.

Excerpt 3

The completion of the transactions contemplated by this **memorandum** will be subject to, among other things, satisfactory completion of financial and legal